Are you a physician or researcher wanting to conduct a clinical trial or undertake medical research into eosinophilic gastrointestinal disorders?
We invite you to submit a research grant
application for projects up to $25,000 that aim to improve the
diagnosis and treatment options for people living with eosinophilic
ausEE Inc. has funded nearly $100,000 in medical research grants since 2015 thanks to the generous support of our donors.
To obtain support from our Medical Research Fund, please complete our Research Grant Application.
If you have already received funding from ausEE Inc. and require an extension or additional funds please complete our Research Extension Application.
June 2019 - We are pleased to announce that we have awarded grant funding of $25,000 to Professor Pete Smith and his research team from Griffith University for an eosinophilic oesophagitis research project. We look forward to sharing with you more about this innovative research in the future.
June 2018 - We are pleased to announce that we have awarded grant funding of $25,000 to Dr Jeremy Rosenbaum of Paediatric Gastroenterology Victoria to help facilitate EoE research projects and improve quality of care. We look forward to sharing with you more about Jeremy’s research in the future.
May 2017 - ausEE has awarded additional grant funding of
$10,000 to Dr Hamish Philpott and Dr Evan Dellon for the continuing work of
their research project titled 'Antigen presentation and acute inflammation in
EoE'. This research is being conducted through the Monash University in collaboration with University of North Carolina, Chapel Hill.
November 2016 - ausEE has awarded grant funding of $8,000 to Dr Hamish Philpott, Dr Evan Dellon and Dr Sanjay Nandurkar for the research project 'Antigen presentation and acute inflammation in EoE'. This project has the potential to streamline the diagnosis and treatment of patients who present with oesophageal eosinophilia.
March 2016 - ausEE has donated $20,000 of its research funds supporting a new study from The University of Newcastle. This study aims to develop new treatments for Eosinophilic Esophagitis (EoE) and other eosinophilic gastrointestinal disorders (EGIDs). Currently there are few options for the management of these conditions. This study aims to create new targeted drug delivery therapies through the use of nanotechnology. The study is being conducted at the University of Newcastle, Hunter Medical Research Institute and John Hunter Hospital, and should be complete within the next two years. We look forward to sharing the results with you.
June 2015 - ausEE has awarded the Royal Prince Alfred Clinical Immunology & Serology team a grant of $8,000 towards its latest research into EoE.
Their research will take blood samples from adult patients before, during and after their treatment in the hopes of identifying certain biomarkers in the blood in order to help detect foods that may be associated with the activation of EoE. If successful it could help in the selection of appropriate dietary restrictions with a blood test, rather than an invasive endoscopy. Although the study focuses on adults with EoE, the results could point specialists in the right direction for EoE management for all ages.
Page last modified: 17 July, 2019